Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools

NCT05415904 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT05415904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05415904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
May 20, 2022
Completion date
July 31, 2024
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hantavirus infection, hantavirus nephropathy